TABLE 2.
Cases with positive culture and/or real-time PCR
| Case no. | Age (yr) | Sexa | Time to 1st pos. sampleb | CFT titerc |
Campylobacter jejuni strain characteristicsd |
|||
|---|---|---|---|---|---|---|---|---|
| Penner serotype | flaA SVR | LOS class | FQR | |||||
| 1 | 53 | M | 10 | 40 | NA | NA | NA | NA |
| 2 | 62 | M | 31 | <10 | O:1, O:44 | Type 1, allele 34 | C | Yes |
| 3 | 74 | F | 4 | 80 | O:19 | Type 232, allele 259 | A | Yes |
| 4 | 55 | M | 4 | ≥640 | O:2 | Type 5, allele 126 | C | No |
| 5 | 17 | M | 9 | 160 | O:2 | Type 1, allele 32 | C | No |
| 6 | 64 | M | 3 | 160 | NA | NA | NA | NA |
| 7 | 23 | M | 4 | ≥640 | NA | NA | NA | NA |
| 8 | 27 | M | 11 | ≥640 | NA | NA | NA | NA |
| 9 | 61 | F | 21 | 20 | O:3, O:13, O:43, O:50 | Type 46, allele 172 | D | Yes |
| 10 | 35 | M | 9 | 160 | O:4, O:13, O:64 | Type 3, allele 161 | A | No |
| 11 | 51 | M | ND | 320 | NA | NAe | NA | NA |
| 12 | 31 | F | 26 | ≥640 | ND | Type 39, allele 76 | B | No |
| 13 | 32 | M | 2 | 320 | NA | NA | NA | NA |
| 14 | 37 | F | 4 | 640 | O:13, O:50, O:64 | Type 42, allele 41 | A | Yes |
| 15 | 24 | M | 5 | 320 | O:19 | Type 3, allele 161 | A | No |
| 16f | 47 | M | 7 | 640 | NA | NA | NA | NA |
M, male; F, female.
Time interval in days between the onset of neurological symptoms and the first positive fecal sample. pos., positive; ND, not determined.
Highest complement fixation test (CFT) titer for cases with multiple serum samples.
The Penner serotype, flaA short variable region (flaA SVR), lipo-oligosaccharide (LOS) class, and resistance to fluoroquinolones (FQR) are shown. NA, not applicable. Strain designations: RPC02C0443 (case 2), RPC02C0782 (case 3), RPC02C0844 (case 4), RPC02C1147 (case 5), RPC03C1847 (case 9), RPC03C2177 (case 10), RPC03C2676 (case 12), RPC05C2874 (case 14), and RPC05C2873 (case 15).
FlaA SVR type 1, allele 567, as determined by direct sequencing of the flaA DNA fragment amplified from stool samples.
Isolation of a C. coli strain.